# FDA Inspection 660333 - Biomat USA Inc. dba Grifols - April 11, 2010

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-dba-grifols/4ab426eb-a4a5-49a5-ab9c-7fe74a275d9e
Source feed: FDA_Inspections

> FDA Inspection 660333 for Biomat USA Inc. dba Grifols on April 11, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 660333
- Company Name: Biomat USA Inc. dba Grifols
- Inspection Date: 2010-04-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1265420 - 2025-03-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-dba-grifols/fb3a0082-ce0b-4027-88d6-3d859458d1e7)
- [FDA Inspection 1265420 - 2025-03-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-dba-grifols/461e0b9f-ac10-43e4-b7c4-0221bd5b5030)
- [FDA Inspection 1056483 - 2018-05-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-dba-grifols/7cbe3add-7001-43f3-b90b-a86c8803d608)
- [FDA Inspection 983368 - 2016-08-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-dba-grifols/d11bafe0-e2e4-4a1c-b660-1b591b389fea)
- [FDA Inspection 872920 - 2014-04-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc-dba-grifols/d6b21859-9359-4d97-89c2-f21e0b6f0589)

Company: https://www.keypedia.com/companies/biomat-usa-inc-dba-grifols/1e24540f-c4b1-4f2a-9062-a3e80a09ae78

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d